Drug Prices | Arnold Ventures

A Reflection on the Biosimilar Pathway As it Turns 10 Years Old

Drug Prices Study: Blocking Generic Drugs is a Costly and Common Pharma Tactic

COVID-19 Reveals Fissures in the Nation’s Prescription Drug Supply Chain

Why Nonprofit Pharma, a Promising Fix for Drug Prices, Faces an Uphill Battle

Community Supervision

Four Key Moments from Trump's State of the Union Address

Video: An 'Erosion' of Protection: The State of Health Care in America

As Democrats Debate in Des Moines, Health Care Reform Tops Iowans' Wish Lists

A Small Win on Drug Pricing Was Added to the U.S. Budget, but Does it Go Far Enough?

Laboratories of Democracy: States Ring in New Year with Ambitious New Health Laws

A Landmark Drug Pricing Bill Just Cleared the House. Now What?

With New Chief in the Wings, Here’s How the FDA Could Wield Influence to Lower Drug Prices

‘The Time to Act Is Now’ on Drug Pricing

Katie West Moved Overseas For School. She Stayed For the Affordable Insulin.

Three Issues That Plague the Drug Pricing System — and the Evidence That Can Shape Solutions

Charity Prescription Drug Programs Can Hurt Rather Than Help, Study Shows

Pill bottles

What Is an Inflationary Rebate, and How Can It Help Bring Down Drug Prices? Explainer

Cross-Border Drug Runs, Deadly Rationing and Black Market Sales Define Life of a Type 1 Diabetes Patient

An injection of insulin

New Study Addresses Vast Price Disparities Between Drugs in the U.S., Other Nations Q&A

Transparency is Just One Piece of the Drug Pricing Puzzle

Poll Reveals Near-Unanimous Call for Aggressive Congressional Action to Lower Prescription Drug Prices

Civica Rx Set to Deliver Essential Antibiotics to Hundreds of Hospitals

Arnold: ‘Independent Body, Not the Payer or Drug Company, Should Decide the Value of a Drug’

Drug Industry Patents Go Under Senate Judiciary Committee’s Microscope

Civica Rx Celebrates Milestone on Path to Stabilizing Supply of Generic Drugs

More stories from:

Criminal Justice